A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators

被引：0
|
作者：
Hamza Y. Garashi
Douglas T. Steinke
Ellen I. Schafheutle
机构：
[1] The University of Manchester,Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health
来源：
Therapeutic Innovation & Regulatory Science | 2022年 / 56卷
关键词：
Pharmacovigilance; Developing countries; Evaluation studies; Programme evaluation; Benchmarking;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：717 / 743
页数：26
相关论文
共 50 条
  • [1] A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators
    Garashi, Hamza Y.
    Steinke, Douglas T.
    Schafheutle, Ellen, I
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2022, 56 (05) : 717 - 743
  • [2] WHO perspective on pharmacovigilance in developing countries
    Couper, Mary R.
    TOXICOLOGY LETTERS, 2006, 164 : S27 - S27
  • [3] Strengths and Weaknesses of the Pharmacovigilance Systems in Three Arab Countries: A Mixed-Methods Study Using the WHO Pharmacovigilance Indicators
    Garashi, Hamza
    Steinke, Douglas
    Schafheutle, Ellen
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (05)
  • [4] Evaluation of Pharmacovigilance System in Sudan Using WHO Indicators
    Elsidig, M.
    Elkheir, H.
    Osman, A.
    DRUG SAFETY, 2018, 41 (11) : 1209 - 1209
  • [5] Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators
    Abimbola O. Opadeyi
    Annie Fourrier-Réglat
    Ambrose O. Isah
    BMC Pharmacology and Toxicology, 19
  • [6] Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators
    Opadeyi, Abimbola O.
    Fourrier-Reglat, Annie
    Isah, Ambrose O.
    BMC PHARMACOLOGY & TOXICOLOGY, 2018, 19
  • [7] Pharmacovigilance System in Arabic Countries: A Systematic Review of 22 Arab Countries
    Alshammari, T.
    Mendi, N.
    Alsowaida, Y.
    DRUG SAFETY, 2018, 41 (11) : 1261 - 1261
  • [8] Assessment of the State of Pharmacovigilance in Secondary Hospitals in the Federal Capital Territory of Nigeria, Using WHO Pharmacovigilance Indicators
    Ezeodimegwu, Augustus Chukwuebuka
    Iloabuchi, Francis Chibuike
    Onyia, Ifunanya Mary-Ann
    Eze, Cynthia Chidubem
    Ezenri, Gabriel
    Onyekwuo, Princess Chidimma
    Ihemegbulam, Chukwuebuka Vincent
    Isah, Abdulmuminu
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (06) : 1148 - 1158
  • [9] Using Machine Learning for Pharmacovigilance: A Systematic Review
    Pilipiec, Patrick
    Liwicki, Marcus
    Bota, Andras
    PHARMACEUTICS, 2022, 14 (02)
  • [10] Pharmacovigilance Systems in Developing Countries: An Evaluative Case Study in Burkina Faso
    Kabore, Lassane
    Millet, Pascal
    Fofana, Souleymane
    Berdai, Driss
    Adam, Caroline
    Haramburu, Francoise
    DRUG SAFETY, 2013, 36 (05) : 349 - 358
12345